Sandeep Laumas is CEO & Chairman at INNOVATE BIOPHARMACEUTICALS, INC. (INNT). They have made 10 open-market trades across 2 companies since 2018, most recently 2025-09-10.
CIK 0001721664
9 open-market purchases totalling $39K since 2018, against 1 sale. Across 9 scored buys the stock is down 31.4% at ninety days, and 29.4 points behind the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 33% | 11% |
| Avg Move | +7.2% | +3.5% | -31.4% |
| Alpha | +8.0% | +5.1% | -29.4% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TIL | SELL | 2025-09-10 | 2025-09-12 | $23.39 | $1.4M | -26.2% | -14.4% | -54.0% |
| INNT | BUY | 2019-06-28 | 2019-07-01 | $1.15 | $5K | -5.2% | -9.5% | -7.8% |
| INNT | BUY | 2019-06-13 | 2019-06-17 | $1.22 | $1K | -4.3% | -4.3% | +0.9% |
| INNT | BUY | 2019-05-22 | 2019-05-23 | $1.38 | $7K | +2.4% | -9.5% | -29.1% |
| INNT | BUY | 2018-11-30 | 2018-12-03 | $2.63 | $8K | +11.4% | -7.9% | -20.9% |
| INNT | BUY | 2018-11-29 | 2018-11-29 | $2.56 | $8K | -2.2% | -14.1% | -28.3% |
| INNT | BUY | 2018-09-07 | 2018-09-10 | $6.10 | $3K | +8.1% | -13.8% | -50.9% |
| INNT | BUY | 2018-08-30 | 2018-08-30 | $5.24 | $3K | +17.0% | +26.9% | -49.3% |
| INNT | BUY | 2018-08-28 | 2018-08-28 | $5.01 | $4K | +20.8% | +37.0% | -47.4% |
| INNT | BUY | 2018-08-28 | 2018-08-30 | $4.90 | $1K | +17.0% | +26.9% | -49.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.